- Older adults with type 2 diabetes (T2D) are less likely than younger adults to receive newer glucose-lowering medications, and increasingly are being prescribed long-acting insulin.
Why this matters
- Guidelines recommend avoiding medications with high hypoglycemic risk in older adults.
- Comparison of T2D treatment data from the National Ambulatory Medical Care Survey (NAMCS) for 25.4 and 24.2 million annual visits for adults aged ≥65 and 30-64 years, respectively, for 2006-2015.
- Funding: NIH.
- During 2014-2015, older vs younger adults had:
- greater use of long-acting insulin: 30.2% vs 22.4% of visits (P=.017).
- They had less use of:
- metformin: 56.0% vs 70.0% (P<.001>
- glucagon-like peptide-1 receptor agonists: 2.9% vs 6.2% (P=.004).
- 65.3% vs 54.8% (P=.016).
- Data represent visits, not patients.
- Possible misclassification of diabetes type.
- NAMCS increased the number of listable medications during survey period.